IDH1 and central nervous system cancer: Next, we stratified patients according to the IDH1/2 mutation status and found that 55.4% of IDH1/2-mutant gliomas originated in the frontal lobe compared to 20.7% of IDH1/2-wild-type tumors (Fig. 5I).